News Releases

Date	Title
11/26/19	Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference
11/21/19	Optinose Announces Pricing of Public Offering of Common Stock
11/20/19	Optinose Announces Proposed Public Offering of Common Stock
11/12/19	Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights
11/01/19	Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019
10/04/19	Optinose Appoints Michael Richardson to New Position of Vice President, Business Development
09/27/19	Optinose to Present at the 2019 Cantor Global Healthcare Conference
09/26/19	OptiNose Announces License Agreement Related to ONZETRA XSAIL
09/17/19	Optinose Announces Departure of Chief Commercial Officer
09/12/19	Optinose Announces $150 Million Debt Financing from Pharmakon
08/12/19	Optinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
08/01/19	Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019
06/20/19	Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
06/19/19	Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
05/09/19	Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights
04/25/19	Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019
03/06/19	Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights
02/27/19	Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019
02/19/19	Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE
02/15/19	Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
02/04/19	Optinose Announces License Agreement

News Releases

News Releases

Investors

Toolkit

Investor Contact

News Releases

News Releases

Keyword Search

Investors

Toolkit

Investor Contact